Alto Ingredients CCO granted 30,794 company shares
Sneed James R reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sneed James R reported acquisition or exercise transactions in this Form 4 filing.
Alto Ingredients, Inc. reported that Chief Commercial Officer James R. Sneed received a grant of 30,794 shares of Common Stock on March 17, 2026. The shares were awarded at no purchase price, increasing his directly held stake to 463,191 shares. This appears to be a routine equity compensation award rather than an open-market trade.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 30,794 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Alto Ingredients (ALTO) report for James R. Sneed?
Was the Alto Ingredients (ALTO) Form 4 transaction a stock purchase or a grant?
What role does James R. Sneed hold at Alto Ingredients (ALTO)?
Is the Alto Ingredients (ALTO) insider transaction part of routine compensation?
AI-generated analysis. How Rhea-AI works. Not financial advice.